{{Rsnum
|rsid=3829963
|Gene=CDKN1A
|Chromosome=6
|position=36676609
|Orientation=plus
|GMAF=0.2796
|Gene_s=CDKN1A
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 1.8 | 13.6 | 84.5
| HCB | 22.1 | 40.4 | 37.5
| JPT | 17.7 | 46.9 | 35.4
| YRI | 15.1 | 49.3 | 35.6
| ASW | 8.8 | 49.1 | 42.1
| CHB | 22.1 | 40.4 | 37.5
| CHD | 23.1 | 50.0 | 26.9
| GIH | 0.0 | 22.8 | 77.2
| LWK | 11.0 | 38.5 | 50.5
| MEX | 5.2 | 46.6 | 48.3
| MKK | 3.2 | 23.2 | 73.5
| TSI | 7.1 | 31.3 | 61.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=21859556
|Title=Association Study of Selected Genetic Polymorphisms and Occurrence of Venous Thromboembolism in Patients With Multiple Myeloma Who Were Treated With Thalidomide
}}

{{PMID Auto
|PMID=19258477
|Title=Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk.
|OA=1
}}

{{PMID Auto
|PMID=20126416
|Title=Identification of single nucleotide polymorphisms in the p21 (CDKN1A) gene and correlations with longevity in the Italian population.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}